⌘K

Home/Filings/4/0001185185-17-000392

4//SEC Filing

Entia Biosciences, Inc. 4

Accession 0001185185-17-000392

CIK 0001408299operating

View on SEC.gov Company Profile

Filed

Feb 15, 7:00 PM ET

Accepted

Feb 16, 7:19 PM ET

Size

10.7 KB

Accession

0001185185-17-000392

Insider Transaction Report

Form 4

Period: 2017-02-14

Entia Biosciences, Inc.ERGO

HAUSMAN MARVIN S MD

DirectorCEO10% Owner

Transactions

Award
Common Stock
2017-02-14+600,000→ 9,438,900 total
Award
Common Stock
2017-02-14+200,000→ 9,638,900 total
Award
Common Stock
2017-02-14+300,000→ 9,938,900 total
Award
Common Stock
2017-02-16+250,000→ 10,188,900 total
Award
Common Stock
2017-02-14$0.17/sh+1,861,170$325,705→ 8,838,900 total

Documents

1 file

4
form4-hausman021617.xmlPrimary
OWNERSHIP DOCUMENT

Issuer

Entia Biosciences, Inc.

CIK 0001408299

Entity typeoperating

IncorporatedNV

Related Parties

1

filerCIK 0001408299

Filing Metadata

Form type: 4
Filed: Feb 15, 7:00 PM ET
Accepted: Feb 16, 7:19 PM ET
Size: 10.7 KB

View on SEC.gov